| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) | 
|---|
| 12/02/1997 | US5693499 Plasmid comprising promoter dna, dna coding signal peptide, dna coding coagulation factor viii amino acid sequences, and termination codon; gene expression  | 
| 12/02/1997 | US5693496 DNA encoding the mouse and human PH30 beta chain protein  | 
| 12/02/1997 | US5693491 Isolated and purified polynucleotide comprising nucleotide sequence encoding receptor having specified amino acid sequence  | 
| 12/02/1997 | US5693482 Neural chest stem cell assay  | 
| 11/30/1997 | CA2206625A1 Cytoplasmic male sterile brassica oleracea plant, and method for obtaining such plant  | 
| 11/27/1997 | WO1997044476A1 Enhanced production of taxanes by cell cultures of taxus species  | 
| 11/27/1997 | WO1997044473A1 Methods for producing and transforming cassave protoplasts  | 
| 11/27/1997 | WO1997044472A1 Nucleic acid molecules coding soluble maize starch synthases  | 
| 11/27/1997 | WO1997044467A1 MITOGEN-ACTIVATED PROTEIN KINASE p38-2 AND METHODS OF USE THEREFOR  | 
| 11/27/1997 | WO1997044466A1 Characterization and use of an isolated uridine diphospho-glucuronosyltransferase  | 
| 11/27/1997 | WO1997044461A2 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers  | 
| 11/27/1997 | WO1997044460A1 Modulators of tissue regeneration  | 
| 11/27/1997 | WO1997044457A1 Polycystic kidney disease gene  | 
| 11/27/1997 | WO1997044455A1 Hematopoietic cytokine receptor  | 
| 11/27/1997 | WO1997044454A2 Human phospholipase inhibitor  | 
| 11/27/1997 | WO1997044453A1 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production  | 
| 11/27/1997 | WO1997044452A1 Human b-cell antigens, related reagents  | 
| 11/27/1997 | WO1997044451A2 Vasoactive amine binding molecules  | 
| 11/27/1997 | WO1997044444A1 Immortalized avian cell lines  | 
| 11/27/1997 | WO1997044443A1 Immortal avian cells  | 
| 11/27/1997 | WO1997044442A1 Isolation, propagation, and directed differentiation of stem cells from central nervous system of mammals  | 
| 11/27/1997 | WO1997044441A1 New antigen presenting cells, a process for preparing the same and their use as cellular vaccines  | 
| 11/27/1997 | WO1997044440A1 Cell line  | 
| 11/27/1997 | WO1997044357A1 Synthetic glucagon binding proteins  | 
| 11/27/1997 | WO1997044356A2 RET LIGAND (RetL) FOR STIMULATING NEURAL AND RENAL GROWTH  | 
| 11/27/1997 | WO1997044070A1 Polysaccharide sponges for cell culture and transplantation  | 
| 11/27/1997 | WO1997044052A1 Immunomodulating compounds comprising d-isomers of amino acids  | 
| 11/27/1997 | WO1997035976A3 Epidermal differentiation factor  | 
| 11/27/1997 | WO1997020937A3 Modification process  | 
| 11/27/1997 | DE19629938C1 Monoclonal antibodies specific for mutated E-Cadherin peptide sequences  | 
| 11/27/1997 | CA2804657A1 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production  | 
| 11/27/1997 | CA2638292A1 Enhanced production of taxanes by cell cultures of taxus species  | 
| 11/27/1997 | CA2258698A1 Immunomodulating compounds comprising d-isomers of amino acids  | 
| 11/27/1997 | CA2257068A1 Isolation, propagation, and directed differentiation of stem cells from central nervous system of mammals  | 
| 11/27/1997 | CA2256039A1 Immortal avian cells  | 
| 11/27/1997 | CA2256038A1 Immortalized avian cell lines  | 
| 11/27/1997 | CA2255712A1 Characterization and use of an isolated uridine diphospho-glucuronosyltransferase  | 
| 11/27/1997 | CA2255579A1 Mitogen-activated protein kinase p38-2 and methods of use therefor  | 
| 11/27/1997 | CA2255541A1 Synthetic glucagon binding proteins  | 
| 11/27/1997 | CA2255538A1 Nucleic acid molecules coding soluble maize starch synthases  | 
| 11/27/1997 | CA2254843A1 Human b-cell antigens, related reagents  | 
| 11/27/1997 | CA2254083A1 Polycystic kidney disease gene  | 
| 11/27/1997 | CA2253541A1 Human phospholipase inhibitor  | 
| 11/26/1997 | EP0808900A2 Polynucleotides and polypeptides associated with benign prostatic hypertrophy  | 
| 11/26/1997 | EP0808899A2 Human marco scavenger receptor (HMarcoSR)  | 
| 11/26/1997 | EP0808897A1 New antigen presenting cells, a process for preparing the same and their use as cellular vaccines  | 
| 11/26/1997 | EP0808896A2 Embryonic stem cells from mice  | 
| 11/26/1997 | EP0808371A1 Expression of sucrose phosphorylase in plants  | 
| 11/26/1997 | EP0808370A1 Stress-tolerant plants and methods of producing the same  | 
| 11/26/1997 | EP0808367A1 Mucosal vascular addressins and uses thereof  | 
| 11/26/1997 | EP0808366A1 IDENTIFICATION OF DEC, (DENTRITIC AND EPITHELIAL CELLS, 205 kDa), A RECEPTOR WITH C-TYPE LECTIN DOMAINS, NUCLEIC ACIDS ENCODING DEC, AND USES THEREOF  | 
| 11/26/1997 | EP0808365A1 Human interleukin-1 receptor accessory protein  | 
| 11/26/1997 | EP0808364A1 Human pancreatic cell lines: developments and uses  | 
| 11/26/1997 | EP0808351A2 Cytoplasmic antiproteinase-2 and cytoplasmic antiproteinase-3 and coding sequences  | 
| 11/26/1997 | EP0808323A1 MUTANTS OF THE Rb AND p53 GENES AND USES THEREOF  | 
| 11/26/1997 | EP0808322A1 RIBOZYMES WITH OPTIMIZED HYBRIDIZING ARMS, STEMS, AND LOOPS, tRNA EMBEDDED RIBOZYMES AND COMPOSITIONS THEREOF  | 
| 11/26/1997 | EP0808169A1 Programmed cell death genes and proteins  | 
| 11/26/1997 | EP0808141A1 Method and apparatus for sodding microvessel cells onto a synthetic vascular graft  | 
| 11/26/1997 | EP0808104A1 AMELIORATION OF HUMAN ERECTILE DYSFUNCTION BY TREATMENT WITH iNOS, AND RELATED NOS AGENTS  | 
| 11/26/1997 | EP0662130B1 A method of producing hepatocyte growth factor and a cell line  | 
| 11/26/1997 | EP0482176B1 Monoclonal antibodies specific for toxin b of clostridium difficile  | 
| 11/26/1997 | EP0466816B1 Method for enhancing transmembrane transport of exogenous molecules  | 
| 11/25/1997 | US5691454 APC antibodies  | 
| 11/25/1997 | US5691447 GC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies  | 
| 11/25/1997 | US5691203 Method for serum-free culture of human vascular endothelial cells  | 
| 11/25/1997 | US5691202 Serum-free medium supplement  | 
| 11/25/1997 | US5691200 Culture product  | 
| 11/25/1997 | US5691186 Filariid cysteine protease genes  | 
| 11/25/1997 | US5691182 Use of isolated domains of type IV collagen to modify cell and tissue interactions  | 
| 11/25/1997 | US5691179 Polynucleotide  | 
| 11/25/1997 | US5691176 Recombinant adeno-associated virus vector packaging cells and methods for use  | 
| 11/25/1997 | US5691175 Immortalized human fetal osteoblastic cells  | 
| 11/25/1997 | US5691155 Detectors, vectors, gene expression  | 
| 11/25/1997 | US5691132 Method for inactivating pathogens in red cell compositions using quinacrine mustard  | 
| 11/25/1997 | US5690929 Use of methioninase and chemotherapy agents in chemotherapy  | 
| 11/25/1997 | US5690928 Administering transforming growth factor  | 
| 11/25/1997 | US5690927 Use of neuro-glial fetal cell lines for transplantation therapy  | 
| 11/25/1997 | US5690926 Pluripotential embryonic cells and methods of making same  | 
| 11/25/1997 | CA2099865C Hepatic growth factor receptor is the met proto-oncogene  | 
| 11/25/1997 | CA1339557C Cell sorting technique and applications thereof  | 
| 11/20/1997 | WO1997043650A1 Method and reagent for monitoring blood levels of antiplatelet compounds  | 
| 11/20/1997 | WO1997043649A1 CHARPERONES CAPABLE OF BINDING TO PRION PROTEINS AND DISTINGUISHING THE ISOFORMS PrPc AND PrP?sc¿  | 
| 11/20/1997 | WO1997043647A1 Dp and e2f protein nuclear localisation signals and their use  | 
| 11/20/1997 | WO1997043436A1 A process for producing a recombinant polypeptide involving the addition of an inhibitor of metal-dependent proteases or chymotrypsins to the cell culture medium  | 
| 11/20/1997 | WO1997043427A1 Production of apomictic seed  | 
| 11/20/1997 | WO1997043416A1 Common gamma chain blocking agents  | 
| 11/20/1997 | WO1997043408A1 Anti-human mp52 monoclonal antibody  | 
| 11/20/1997 | WO1997043304A1 Novel compounds  | 
| 11/20/1997 | WO1997043303A1 Novel compounds  | 
| 11/20/1997 | WO1997042835A1 Purification of biologically active peptides from milk  | 
| 11/20/1997 | WO1997035994A3 Cytochrome p450 transducing retroviral vectors  | 
| 11/20/1997 | WO1997035538A3 Tumor necrosis factor alpha convertase  | 
| 11/20/1997 | WO1997030354A3 Foetal cell analysis  | 
| 11/20/1997 | DE19619918A1 Nucleinsäuremoleküle codierend lösliche Stärkesynthasen aus Mais Nucleic acid molecules encoding soluble starch from maize  | 
| 11/20/1997 | CA2254857A1 Anti-human mp52 monoclonal antibody  | 
| 11/20/1997 | CA2254839A1 Production of apomictic seed  | 
| 11/20/1997 | CA2253942A1 Common gamma chain blocking agents  | 
| 11/20/1997 | CA2253402A1 Method and reagent for monitoring blood levels of antiplatelet compounds  | 
| 11/19/1997 | EP0807686A2 Interleukin-1 beta converting enzyme like apoptotic protease-7  | 
| 11/19/1997 | EP0807685A2 Sucrose phosphate synthase (sps), its process for preparation, its cdna and utilization of cdna to modify the expression if sps in the plant cells  |